FIELD: medicine.
SUBSTANCE: the present innovation refers to reendoprosthetics in case of purulent arthritis of knee joint. On removing the elements of endoprosthesis and thorough debridement one should implant an articulating spacer that consists of the endoprosthesis' sterilized femoral component and a tibial component designed intrasurgically out of bony cement at addition of about 4-6 g gentamycinum and about 1-2 g vancomicin/cement mass. Both components should be applied at using bony cement that contains the same antibiotics and in the concentration being similar to that applied while preparing a tibial component. The innovation keeps articular function before reendoprosthetics.
EFFECT: higher efficiency of therapy.
5 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR MANUFACTURING ARTICULATING REINFORCED CEMENT ANTIBACTERIAL KNEE JOINT SPACER | 2018 |
|
RU2711608C1 |
| METHOD OF KNEE JOINT ARTICULATING SPACER DEVICE FITTING WITH FEMORAL DISTAL METAEPIPHYSIS MARGINAL DEFECT | 2019 |
|
RU2701317C1 |
| METHOD OF TREATING PERIPROSTHETIC INFECTION IN KNEE JOINT REPLACEMENT | 2020 |
|
RU2725272C1 |
| METHOD OF MAKING INDIVIDUAL ARTICULATORY 3D ENDOPROSTHESIS REPLACEMENT SPACER OF KNEE-JOINT | 2020 |
|
RU2736119C2 |
| MAJOR FEMORAL AND SHIN CONDYLE DEFECT REPLACEMENT TECHNIQUE IN INSPECTIVE KNEE JOINT REPLACEMENT | 2007 |
|
RU2355324C2 |
| METHOD OF TREATING PERIPROSTHETIC INFECTION OF KNEE JOINT WITH PRESENCE OF METAEPIDIOPHYSEAL DEFECTS | 2020 |
|
RU2737653C1 |
| METHOD OF TREATING PATIENTS WITH PERIPROSTHETIC INFECTION AFTER HIP REPLACEMENT | 2023 |
|
RU2825106C1 |
| METHOD FOR MANUFACTURING A CEMENT SPACER FOR ETIOTROPIC LOCAL ANTIBACTERIAL THERAPY FOR INFECTIOUS AFFECTIONS OF BONES AND JOINTS | 2020 |
|
RU2754075C1 |
| METHOD FOR COMPLEX EMPIRICAL ANTIBACTERIAL THERAPY OF IMPLANT-ASSOCIATED ORTHOPEDIC INFECTIONS | 2015 |
|
RU2641608C2 |
| METHOD OF TREATING PATIENTS WITH REUMATOIDAL ARTHRITIS WITH FIXED VALGUS AND STABLE FLEXION CONTRACTURE OF KNEE JOINT | 2008 |
|
RU2373876C1 |
